Rps19 |
Knockout allele |
Homozygote-early embryonic lethality; Heterozygote-no hematologic or developmental phenotype; normal Rps19 expression |
Compensation mechanisms in mice |
13, 14
|
Rps19 |
Xenograft immunodeficient mice with human DBA cells |
Improved engraftment and erythropoiesis in RPS19 rescued marrow |
Invokes RPS19 haploinsufficiency in DBA; possible role for gene therapy |
22, 23
|
Rps19 |
Transgene carrying a pathogenic missense mutation (β-actin promoter) |
Ubiquitous expression-embryonic lethal; Inducible expression-growth retardation, anemia, reduced erythroid progenitors and red blood cells, rRNA processing defects |
RPS19 missense mutations may act through dominant negative mechanism |
7 |
Rps19 |
Knockdown in erythroid progenitors (ex vivo) |
Impaired proliferation, G1 arrest, induction of p53, decreased Myb and Kit
|
p53-induced cell cycle arrest results in decreased Kit and impaired erythropoiesis |
26 |
Rps19 |
ENU-induced missense mutation |
Homozygote-early embryonic lethality; Heterozygote-dark skin, white belly spot, growth retardation, mild anemia |
Activation of p53 mediates tissue specific phenotypes |
16 |
Rps6 |
Conditional allele |
Liver deletion (2 alleles)-proliferation defect after partial hepatectomy; Ubiquitous deletion (one allele)-embryonic lethality, prolonged cell cycle, increased apoptosis; T-cell deletion (2 alleles)-impaired T-cell development; T-cell deletion (one allele)-decreased T-cell survival, proliferation defect in activated T-cells; Keratinocyte deletion (one allele)-dark skin; Melanocyte deletion (one allele)-light skin |
Cell cycle checkpoint responds to defects in ribosome biogenesis; activation of p53 mediates tissue specific phenotypes |
15,16, 30, 31
|
Rpl24 |
Spontaneous mutation |
White spotting, retinal defects, kinked tail, growth retardation; mutant cells have a prolonged cell cycle and a growth disadvantage |
Phenotypes are mediated by p53 |
12, 32
|
5q deletion (Rps14) |
Conditional deletion of ~500kb on 5qsyntenic region (Rps14 and 8 other genes) |
Macrocytic anemia, megakaryocyte dysplasia, bone marrow apoptosis, progenitor cell defects |
Hematopoietic phenotypes are mediated by p53 |
33 |